A Study of LY4005130 in Adult Participants With Non-Segmental Vitiligo
Conditions
Vitiligo · Non-Segmental Vitiligo (NSV)
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Medical Dermatology Specialists, Phoenix, Arizona, United States
Contact: Principal Investigator (Lindsay Ackerman)Saguaro Dermatology - Phoenix, Phoenix, Arizona, United States
Contact: Principal Investigator (Dathan Hamann)Center For Dermatology Clinical Research, Inc., Fremont, California, United States
Contact: Principal Investigator (Sunil Dhawan)Northridge Clinical Trials, Northridge, California, United States
Contact: Principal Investigator (Navid Ezra)Cura Clinical Research - Oxnard, Oxnard, California, United States
Contact: Principal Investigator (Michael Lin)Cura Clinical Research - Santa Clarita - Kelly Johnson Parkway, Santa Clarita, California, United States
Contact: Principal Investigator (Bernard Raskin)Health Clinical Research, LLC, Miami, Florida, United States
Contact: Principal Investigator (Soroush Aghigh)K2 Medical Research - Tampa, Tampa, Florida, United States
Contact: Principal Investigator (Kelley Wilson)Advanced Medical Research, PC., Sandy Springs, Georgia, United States
Contact: Principal Investigator (Jamie Weisman)Dawes Fretzin Clinical Research Group, LLC, Indianapolis, Indiana, United States
Contact: Principal Investigator (Scott Fretzin)Brigham and Women's Hospital, Boston, Massachusetts, United States
Contact: Principal Investigator (Arash Mostaghimi)Revival Research Institute, LLC, Troy, Michigan, United States
Contact: Principal Investigator (Ali Moiin)Stracskin, Portsmouth, New Hampshire, United States
Contact: Principal Investigator (Abel Jarell)Equity Medical, The Bronx, New York, United States
Contact: Principal Investigator (Maira Fonseca)Accurate Clinical Research, Inc, Humble, Texas, United States
Contact: Principal Investigator (Chinelo Fangtang)Texas Dermatology and Laser Specialists - San Antonio - South New Braunfels Avenue, San Antonio, Texas, United States
Contact: Principal Investigator (John Browning)Jordan Valley Dermatology & Research Center, South Jordan, Utah, United States
Contact: Principal Investigator (Douglass Forsha)Clinical Research Partners, LLC, Richmond, Virginia, United States
Contact: Principal Investigator (Robert Call)Anima Diepenbeek, Diepenbeek, Belgium
Contact: Principal Investigator (Hilde Bollen)UZ Gent, Ghent, Belgium
Contact: Principal Investigator (Reinhart Speeckaert)Centre Hospitalier Universitaire de Liège - Domaine Universitaire du Sart Tilman, Liège, Belgium
Contact: Principal Investigator (ARJEN NIKKELS)INTERMED Groupe Sante, Chicoutimi, Canada
Contact: Principal Investigator (Doria Grimard)DermEffects, London, Canada
Contact: Principal Investigator (Wei Jing Loo)Dar Clinical Research - Ottawa - Hunt Club Road, Ottawa, Canada
Contact: Principal Investigator (Reetesh Bose)The Centre for Dermatology, Richmond Hill, Canada
Contact: Principal Investigator (Mani Raman)Research Toronto, Toronto, Canada
Contact: Principal Investigator (Sameh Hanna)SIMa Recherche, Verdun, Canada
Contact: Principal Investigator (Simon Nigen)Peking University People's Hospital, Beijing, China
Contact: Principal Investigator (Jianzhong Zhang)Hangzhou Third People's Hospital, Hangzhou, China
Contact: Principal Investigator (Xiuzu Song)Shanghai Skin Disease Hospital, Shanghai, China
Contact: Principal Investigator (Yuling Shi)The University of Hong Kong-Shenzhen Hospital, Shenzhen, China
Contact: Principal Investigator (zhenying zhang)Centrum Badan Klinicznych PI-House sp. z o.o., Gdansk, Poland
Contact: Principal Investigator (Aleksandra Okuniewska)Diamond Clinic, Krakow, Poland
Contact: Principal Investigator (Barbara Rewerska)Dermedic Jacek Zdybski, Ostrowiec Świętokrzyski, Poland
Contact: Principal Investigator (Jacek Zdybski)Centrum Medyczne Ginemedica, Wroclaw, Poland
Contact: Principal Investigator (Justyna Kwapisz)
Study leads
Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 8 AM - 8 PM Eastern time (UTC/GMT - 5 hours, EST)
Study Director
Eli Lilly and Company